Plavix Ruling Raises Learned Intermediary Questions

Law360, New York (December 4, 2017, 12:31 PM EST) -- A federal judge in New Jersey recently granted summary judgment to Plavix drug makers Bristol Myers-Squibb Company (BMS), Sanofi-Aventis U.S. LLC, Sanofi-Aventis U.S. Inc. and Sanofi-Synthelabo Inc. in a lawsuit alleging that the plaintiff’s gastrointestinal bleeding was caused by the defendants’ prescription drug Plavix.

The plaintiff alleged that she suffered injuries as a result of the defendants’ design, development, manufacture, promoting, marketing, distributing, labeling and sale of Plavix, an anti-clotting medication.

Plavix was initially approved by the FDA for individuals with recent heart attack, stroke (including...
To view the full article, register now.